Zydus Wellness Ltd (ZYDUSWELL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Zydus Wellness Ltd on NSE and BSE, with an AI summary of each filing.
Audio recording of the Investor Call on unaudited financial results for the quarter and half year ended on September 30, 2026
Audio / Video · 04 Nov 2026, 4:54 am
Zydus Wellness Releases Audio Recording of Q2FY27 Investor Earnings Call Zydus Wellness informed exchanges on 3rd Nov'26 that the audio recording of its investor call covering unaudited financial results for the quarter and half-year ended 30th Sep'26 (Q2FY27) is available on the company's official website pursuant to Regulation 30 of SEBI LODR Regulations.
Press Release
Press Release · 03 Nov 2026, 6:16 pm
Zydus Wellness Reports Robust Q2 FY27 Results with 74.6% Sales Growth For Q2 FY27, Zydus Wellness reported consolidated net sales of ₹11,227 million, up 74.6% YoY from ₹6,429 million, alongside a 271.7% YoY surge in EBITDA to ₹855 million. For H1 FY27, sales rose 70.1% YoY to ₹25,526 million, with EBITDA increasing 83.2% YoY to ₹3,272 million. Performance was driven by double-digit growth across Sugar Free, Nutralite, Complan, and RiteBite Max Protein. Skin & Hair Care grew 37.5% YoY, led by Everyuth commanding dominant shares in scrubs (50.2%) and peel-offs (75.6%).
Investor presentation
Investor Presentation · 03 Nov 2026, 6:12 pm
Zydus Wellness Q2 FY27 Financial and Operational Performance Overview Zydus Wellness reported robust Q2 FY27 net sales growth of 74.6% YoY to INR 11,227 million, with revenue from operations rising 73.2% YoY to INR 11,266 million. Gross margin expanded 870 bps YoY to 61.1%, boosted by core strength and the higher-margin Comfort Click acquisition. EBITDA surged 271.7% YoY to INR 855 million, expanding margins to 7.6%. PAT turned positive to INR 51 million versus a loss of INR 528 million in Q2 FY26, while adjusted net profit reached INR 545 million with an adjusted EPS of INR 1.71.
Outcome of Board Meeting dated November 3, 2026
Outcome · 03 Nov 2026, 6:07 pm
Unaudited Financial Results for the quarter and half year ended on September 30, 2026
Financial Result · 03 Nov 2026, 6:04 pm
Zydus Wellness Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 11,266 (+73.2% YoY | -21.6% QoQ) ■ EBITDA: 855 (+271.7% YoY | -64.6% QoQ) ■ EBITDA Margin (%): 7.6 (+405 bps YoY | -923 bps QoQ) ■ PAT: 51.0 (Loss to Profit YoY | -95.7% QoQ) ■ EPS (INR): 0.16 (Loss to Profit YoY | -95.7% QoQ)
Zydus Wellness Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 03 Nov 2026, 6:01 pm
Clarification on recent news item dated October 22, 2026
Others (Uncategorized) · 23 Oct 2026, 3:55 pm
Zydus Wellness Clarifies FSSAI Notice on Product Label Claims Zydus Wellness responded to stock exchange queries regarding media reports about an FSSAI notice over alleged misleading product claims. The company received the notice on 24th Sep'26 and replied on 4th Oct'26, clarifying that its product label statements are factual and scientifically substantiated. Zydus Wellness confirmed that the news item has no material impact on the company and that all price-sensitive and material information continues to be disclosed in compliance with SEBI Listing Regulations.
The Exchange has sought Clarification from Zydus Wellness Ltd with reference to the media report appearing on https://www.firstpost.com dated October 22, 2026 titled "FSSAI issues notices ....
Others (Uncategorized) · 22 Oct 2026, 10:33 pm
Schedule of Analyst / Institutional Investors' call on November 3, 2026
Intimation · 03 Nov 2026, 4:00 pm
Zydus Wellness Schedules Q2FY27 Earnings Conference Call for Nov'26 Zydus Wellness Limited will host an analyst and institutional investor conference call on 3rd Nov'26 at 16:00 IST to discuss its unaudited financial results for Q2FY27 and H1 ended 30th Sep'26. The call will feature key management representatives, including CEO Tarun Arora and CFO Umesh Parikh, and is organized in coordination with ICICI Securities.
ESG rating
Others (Uncategorized) · 16 Oct 2026, 9:07 pm
Zydus Wellness Assigned 'Leader' Category ESG Rating of 72 by NSRAL NSE Sustainability Ratings and Analytics Limited (NSRAL), a SEBI-registered ESG rating provider, has assigned Zydus Wellness Limited an overall ESG rating of 72 for FY26. The assigned score places the company in the 'leader' category. The unsolicited rating was independently prepared by NSRAL based on publicly available data, with the official report received by the company on 15th Oct'26.
ZYDUS WELLNESS LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve unaudited financial results ....
Intimation · 03 Nov 2026, 5:30 am
Zydus Wellness Board Meeting Scheduled for Nov'26 to Consider Q2 Results Zydus Wellness Limited announced that its Board of Directors will meet on 3rd Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for directors and designated persons remains closed until 5th Nov'26 and will reopen on 6th Nov'26.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
Change in Senior Management Personnel
Change in Management · 18 Sept 2026, 11:32 pm
Zydus Wellness Chief Marketing Officer Arijit Sengupta Resigns Zydus Wellness Limited announced the resignation of Chief Marketing Officer and Senior Management Personnel Arijit Sengupta, effective from the close of business hours on 18th Sep'26. In his resignation letter, Sengupta cited relocation to Mumbai due to personal circumstances as the primary reason for stepping down from his executive role.
Clarification on volume movement
Others (Uncategorized) · 08 Sept 2026, 4:29 pm
Zydus Wellness Clarifies Recent Trading Volume Surge Is Purely Market Driven Zydus Wellness responded to BSE's query on 8th Sep'26 regarding a significant increase in the trading volume of its equity shares across exchanges. The company clarified that all requisite disclosures under Regulation 30 of SEBI Listing Regulations have been made timely and no undisclosed events or impending announcements exist that could impact price or volume behavior. Management stated the recent volume movement is purely market-driven, beyond the company's control or knowledge, confirming ongoing compliance with all regulatory disclosure mandates.
The Exchange has sought clarification from Zydus Wellness Ltd on September 8, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Others (Uncategorized) · 08 Sept 2026, 3:44 pm
ESG rating assigned by SES
Others (Uncategorized) · 03 Sept 2026, 10:08 pm
Zydus Wellness Secures Upgraded ESG Score of 71.7 from SES Zydus Wellness announced that SEBI-registered rating provider SES ESG Research voluntarily assigned the company an ESG score of 71.7 on 2nd Sep'26. This marks a marginal improvement from the score of 70 achieved during FY24-25. The voluntary rating update, disclosed under SEBI Regulation 30, reflects the company's incremental progress in its environmental, social, and governance disclosures and operational practices.
Analyst / Institutional Investors' Conference on September 22, 2026
Intimation · 02 Sept 2026, 10:32 pm
Zydus Wellness to Participate in Anand Rathi G-200 Summit on 22nd Sep'26 Zydus Wellness management is scheduled to participate in the Anand Rathi G-200 Summit 2026 in Mumbai on 22nd Sep'26. The institutional investor conference, hosted by Anand Rathi, will feature both group and one-on-one meetings with analysts and investors.
Transcript of 32nd Annual General Meeting
Annual General Meeting · 02 Sept 2026, 10:24 pm
Appointment of Mr. Kapil Sharma as Chief Revenue Officer forming part of Senior Management of the Company
Change in Management · 01 Sept 2026, 3:16 pm
Zydus Wellness Appoints P&G Veteran as Chief Revenue Officer Zydus Wellness has appointed Mr. Kapil Sharma as Chief Revenue Officer (India and Indian subcontinent), effective 1st Sep'26. He joins the senior management team, bringing 28+ years of commercial leadership experience. Sharma previously spent 25 years at Procter & Gamble, most recently as VP for the Gillette grooming portfolio in India. His experience spans sales, e-commerce, digital commerce strategy, and market strategy, including leading P&G's global digital commerce strategy from the USA. He holds an MBA in Marketing from S.P. Jain Institute.
Disclosure under SEBI (PIT) Regulations, 2015
Others (Uncategorized) · 25 Aug 2026, 3:22 am
Zydus Wellness: Promoter Group Share Transmission Disclosed Zydus Wellness disclosed an off-market share transmission within its Promoter Group. On Aug 19, '26, Mr. Prashant Babubhai Patel received 27,250 equity shares (0.00% of total) from the late Jasodaben Babubhai Patel, another Promoter Group member. Prior to this, Mr. Patel held no shares. The transaction value was nil, as it was a transmission. The company was intimated on Aug 21, '26. This change in holding within the promoter family does not alter the overall promoter group shareholding percentage.
Credit rating assigned by Care Ratings Limited
Others (Uncategorized) · 19 Aug 2026, 11:54 pm
Zydus Wellness Subsidiary Assigned CARE AA+ Stable for Long-Term Bank Facilities Care Ratings has assigned a 'CARE AA+; Stable' rating to the ₹12.00 crore long-term bank facilities of Zydus Wellness Products Limited (ZWPL), a wholly-owned subsidiary of Zydus Wellness Ltd (ZWL). The rating, intimated on 18 Aug'26, reflects ZWPL's established FMCG presence, strong brand portfolio, and strategic importance to parent Zydus Lifesciences. Key constraints include moderate margins, low return ratios, and vulnerability to raw material volatility and intense competition. The rating is valid for one year from 22 Jul'26.
Transcript of the Earnings Conference call held on August 4, 2026
Transcript · 10 Aug 2026, 4:50 pm
Zydus Wellness Q1FY27: Strong Sales Growth Offset by Seasonal Weakness Zydus Wellness reported strong Q1FY27 results with consolidated net sales growing 66.7% YoY to INR 14,299 million, driven by the Comfort Click business. EBITDA rose 55.3% to INR 2,417 million. Domestic business grew 4.6%, while international operations saw 24.8% like-for-like growth. Skin & Hair Care (+34.5%) and Food & Nutrition (+16%) performed well, but the seasonal brand portfolio declined 12% due to unseasonal rains impacting Nycil and Glucon-D. Adjusted net profit, excluding amortization of acquired brands, grew 26.5% for the quarter.
ESG rating received from Crisil
Others (Uncategorized) · 09 Aug 2026, 12:07 am
Zydus Wellness Receives Upgraded ESG Rating from CRISIL CRISIL has assigned Zydus Wellness an ESG rating of 'Crisil ESG 66' and a fresh 'Crisil Core ESG 70' rating for FY26. The overall ESG score improved from 59 in FY25, leading to a category upgrade from "Adequate" to "Strong". This new rating, based on publicly disclosed information, reflects enhanced performance across environmental, social, and governance parameters. The company received the intimation from CRISIL on 7th Aug'26. This upgrade highlights the company's strengthening commitment to sustainability practices, a key factor for ESG-focused investors.
Schedule of Analyst / Institutional Investors' Conference to be held on August 14, 2026
Intimation · 08 Aug 2026, 3:38 pm
Zydus Wellness to Participate in Equirus Annual India Conference Zydus Wellness announced its representatives will participate in the Equirus Annual India Conference 2026, hosted by Equirus Securities. The event is scheduled for Fri, Aug 14, '26, in Mumbai. Management will engage with analysts and institutional investors through group and one-on-one meetings. This engagement is disclosed under SEBI's Regulation 30 listing obligations.